Blackstone Life Sciences announces a $455 million co-financing collaboration to develop the Boston Scientific VITALYST heart pump for patients with cardiogenic shock -. Company announcement - FT.com.
Blackstone Life Sciences announces a $455 million co-financing collaboration to develop the Boston Scientific VITALYST heart pump for patients with cardiogenic shock -. Company announcement - FT.com.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in